Information about D'haen Pharma
My details
*
*
*

D'haen Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0843.099.155

VAT liability
Yes
Established
15-01-2012
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from D'haen Pharma

2024 2023 2022 2021
Profit/Loss 72,524 3 % 70,397 -8 % 76,162 14 % 67,082
Equity 271,253 9 % 248,729 -7 % 267,332 14 % 234,170
Gross margin 125,113 7 % 116,546 37 % 84,804 -15 % 100,032

Publications from D'haen Pharma

Date Publication
10-02-2023 Registered Office (NL)
11-03-2020 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations - Appointments (NL)
15-02-2016 Registered Office (NL)
08-02-2012 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of D'haen Pharma?
The VAT number of D'haen Pharma is BE 0843.099.155.
Wat is the PEPPOL ID of D'haen Pharma?
The PEPPOL ID of D'haen Pharma is 0208:0843099155. Log in or start a free trial to see the full overview.
When was D'haen Pharma founded?
D'haen Pharma was founded on 15-01-2012.
What is the address of D'haen Pharma?
The current registered office of D'haen Pharma is located at Faliestraat 96, 9620 Zottegem.
When was the last time D'haen Pharma filed their annual financial statements?
The most recent financial statements of D'haen Pharma were filed on 03-07-2025.
How many employees does D'haen Pharma have?
There are currently no employees working at D'haen Pharma or no workforce information is available.
What is the annual turnover of D'haen Pharma?
At the time of its most recent financial statements, D'haen Pharma did not publish any turnover figures. D'haen Pharma reported a gross margin of €125,113.29.